Cora Gold Limited (CORA.L)
GBp 2.4
(0.0%)
GBp 2.4
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 1.07 Million | 1.33 Million | 1.06 Million | 773 Thousand | 793 Thousand | 461 Thousand |
| Selling, General and Administrative Expenses | 286 Thousand | 439 Thousand | 289 Thousand | 277 Thousand | 293 Thousand | 278 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 893 Thousand | 779 Thousand | 496 Thousand | 500 Thousand | 183 Thousand |
| Cost and Expenses | 1.07 Million | 1.33 Million | 1.06 Million | 773 Thousand | 793 Thousand | 461 Thousand |
| Operating Income | -288.48 Thousand | -866 Thousand | -1.06 Million | 23 Thousand | -793 Thousand | -4.42 Million |
| Interest Expense | 2.45 Million | - | - | - | - | - |
| Income Tax Expense | 2.45 Million | 896 Thousand | -341 Thousand | 1.49 Million | 44 Thousand | -7.99 Million |
| Earnings before Tax | -2.51 Million | -1.76 Million | -727 Thousand | -1.47 Million | -837 Thousand | 3.57 Million |
| Net Income | -4.96 Million | -2.65 Million | -386 Thousand | -2.97 Million | -881 Thousand | 11.57 Million |
| Earnings Per Share Basic | -0.02 | -0.01 | -0.00 | -0.03 | -0.02 | 0.21 |
| Earnings Per Share Diluted | -0.02 | -0.01 | -0.00 | -0.03 | -0.02 | 0.21 |
| Weighted Average Shares Outstanding | 289.55 Million | 231.39 Million | 175.68 Million | 96.95 Million | 55.8 Million | 54.97 Million |
| Weighted Average Shares Outstanding (Diluted) | 289.55 Million | 231.39 Million | 175.68 Million | 96.95 Million | 55.8 Million | 54.97 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -60 Thousand | -866 Thousand | -1.06 Million | 23 Thousand | -793 Thousand | -4.42 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 490.2 Thousand | 491.61 Thousand | 480.87 Thousand | 1.07 Million | 469.21 Thousand | 733.66 Thousand |
| Selling, General and Administrative Expenses | 490.2 Thousand | 491.61 Thousand | 480.87 Thousand | - | 469.21 Thousand | 733.66 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | 786 Thousand | - | - |
| Cost and Expenses | 490.2 Thousand | 491.61 Thousand | 480.87 Thousand | 1.07 Million | 469.21 Thousand | 733.66 Thousand |
| Operating Income | -490.2 Thousand | -491.62 Thousand | -480.87 Thousand | -60 Thousand | -469.22 Thousand | -733.67 Thousand |
| Interest Expense | 29.25 Thousand | 126.09 Thousand | 393.29 Thousand | 2.45 Million | - | - |
| Income Tax Expense | - | -43.81 Thousand | -122.08 Thousand | 2.45 Million | -54.88 Thousand | -86.06 Thousand |
| Earnings before Tax | -369.23 Thousand | -272.94 Thousand | -2.11 Million | -2.51 Million | -1.32 Million | -735.98 Thousand |
| Net Income | -369.23 Thousand | -272.94 Thousand | -2.11 Million | -4.96 Million | -1.32 Million | -735.98 Thousand |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.01 | - | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.01 | - | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 420.2 Million | 370.21 Million | 338.57 Million | 289.55 Million | 289.55 Million | 289.55 Million |
| Weighted Average Shares Outstanding (Diluted) | 420.2 Million | 370.21 Million | 338.57 Million | 289.55 Million | 289.55 Million | 289.55 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -490.2 Thousand | -491.62 Thousand | -480.87 Thousand | - | -469.22 Thousand | -733.67 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
PPLPHARMA
ATAP
CBSM
FRERF
GOGL
OILRF